What is Jesus Vera Aguilera's specialty?

Jesus Vera Aguilera (NPI 1265872196) is a Medicare-billing provider whose primary specialty is Hematology-Oncology in Duluth, MN.

Where does Jesus Vera Aguilera practice?

Jesus Vera Aguilera practices in Duluth, MN, based on the location reported in the CMS Medicare provider datasets for NPI 1265872196.

How much does Medicare pay Jesus Vera Aguilera?

Jesus Vera Aguilera (NPI 1265872196) received approximately $2.1M in total Medicare Part B payments, serving 374 beneficiaries, per the CMS Medicare Physician & Other Practitioners dataset.

PROVIDER PROFILE · NPI 1265872196

Jesus Vera AguileraM.D.

PRACTICETHE DULUTH CLINIC, LTDSee all providers at this practice →

Hematology-OncologyDuluth, MNI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,933

Unique beneficiaries

—

Total services

65,465

Distinct HCPCS

Medicare payment

$1.1M

Peer benchmark

Total Medicare services vs. 189 Hematology-Oncology providers in MN — top quintile (cohort median 389).

PRESCRIBING · PART D · 2024

Total Rx claims

659

Beneficiaries

—

Total drug cost

$1.3M

Distinct drugs

Brand share

28.7%

Top prescribed drugs

Prednisone89 claims

Oxycodone Hcl62 claims

Dexamethasone44 claims

Acyclovir39 claims

Apixaban36 claims

QUALITY · MIPS · 2024

Final MIPS score

89.2

Quality

72.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

98.0

Payment adjustment

0.60%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$8K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$8K

Top paying entities

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$8K

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 240057

Hospital

CCN 240115

Hospital

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history